Evidence map›Paper›PMID 41776165›Full record

ArticleNature communications2026

Chemodivergent Coupling of 1,3-Enynes with Anilines to Access Dihydropyrrole Skeleton under Palladium Catalysis.

Su-Yang Xu, Xue-Ting Li, Zhi-Hui Wang, Ding-Wei Ji, Qing-An Chen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Su-Yang XuDalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, China.
Xue-Ting LiDalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, China.
Zhi-Hui WangDalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, China.
Ding-Wei JiDalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, China. dingweiji@dicp.ac.cn.
Qing-An ChenDalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian, China. qachen@dicp.ac.cn.ORCID http://orcid.org/0000-0002-9129-2656

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22201281
6 · The paper itself

Abstract

2,5-Dihydropyrroles are prevalent structural motifs in various natural products and biologically active molecules. Conventional methods for constructing these heterocycles often rely on elaborate multi-step procedures or complex starting materials. Herein, we describe a palladium-catalyzed chemodivergent protocol for synthesizing functionalized 2,5-dihydropyrrole scaffolds from readily accessible 1,3-enynes and anilines. By modulating the relative rates of the selectivity-determining steps, either two-component annulation or three-component telomerization can be selectively achieved, affording two distinct types of functionalized 2,5-dihydropyrroles in excellent yields and with high selectivities. Mechanistic studies reveal that the reaction initially proceeds through 1,4-hydroamination of 1,3-enynes to generate an aminomethyl allene intermediate, followed by an intramolecular annulation affording 2-substituted 2,5-dihydropyrroles. This process is significantly accelerated in the presence of Pd(II) catalysts. However, employing Pd(0) precursors, strong acids, and excess ligand effectively decelerates this pathway, diverting the selectivity towards reaction with a second equivalent of 1,3-enyne to yield the telomeric products. This study not only provides an atom-economical method for constructing the 2,5-dihydropyrrole core but also offers a valuable strategy for the development of telomerization chemistry.

Identifiers

PMID41776165
PMCPMC13066409

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.